163 related articles for article (PubMed ID: 28745630)
1. Subpial Adeno-associated Virus 9 (AAV9) Vector Delivery in Adult Mice.
Tadokoro T; Miyanohara A; Navarro M; Kamizato K; Juhas S; Juhasova J; Marsala S; Platoshyn O; Curtis E; Gabel B; Ciacci J; Lukacova N; Bimbova K; Marsala M
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745630
[TBL] [Abstract][Full Text] [Related]
2. Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs.
Miyanohara A; Kamizato K; Juhas S; Juhasova J; Navarro M; Marsala S; Lukacova N; Hruska-Plochan M; Curtis E; Gabel B; Ciacci J; Ahrens ET; Kaspar BK; Cleveland D; Marsala M
Mol Ther Methods Clin Dev; 2016; 3():16046. PubMed ID: 27462649
[TBL] [Abstract][Full Text] [Related]
3. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
[TBL] [Abstract][Full Text] [Related]
4. Subpial AAV Delivery for Spinal Parenchymal Gene Regulation in Adult Mammals.
Bravo-Hernández M; Tadokoro T; Marsala M
Methods Mol Biol; 2019; 1950():209-233. PubMed ID: 30783976
[TBL] [Abstract][Full Text] [Related]
5. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS.
Bravo-Hernandez M; Tadokoro T; Navarro MR; Platoshyn O; Kobayashi Y; Marsala S; Miyanohara A; Juhas S; Juhasova J; Skalnikova H; Tomori Z; Vanicky I; Studenovska H; Proks V; Chen P; Govea-Perez N; Ditsworth D; Ciacci JD; Gao S; Zhu W; Ahrens ET; Driscoll SP; Glenn TD; McAlonis-Downes M; Da Cruz S; Pfaff SL; Kaspar BK; Cleveland DW; Marsala M
Nat Med; 2020 Jan; 26(1):118-130. PubMed ID: 31873312
[TBL] [Abstract][Full Text] [Related]
6. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
Bailey RM; Rozenberg A; Gray SJ
Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
[TBL] [Abstract][Full Text] [Related]
7. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
[TBL] [Abstract][Full Text] [Related]
8. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
[TBL] [Abstract][Full Text] [Related]
9. Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
Bucher T; Dubreil L; Colle MA; Maquigneau M; Deniaud J; Ledevin M; Moullier P; Joussemet B
Gene Ther; 2014 May; 21(5):522-8. PubMed ID: 24572783
[TBL] [Abstract][Full Text] [Related]
10. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
[TBL] [Abstract][Full Text] [Related]
12. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
[TBL] [Abstract][Full Text] [Related]
13. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs.
Federici T; Taub JS; Baum GR; Gray SJ; Grieger JC; Matthews KA; Handy CR; Passini MA; Samulski RJ; Boulis NM
Gene Ther; 2012 Aug; 19(8):852-9. PubMed ID: 21918551
[TBL] [Abstract][Full Text] [Related]
14. Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration.
Liu Y; Keefe K; Tang X; Lin S; Smith GM
PLoS One; 2014; 9(2):e87447. PubMed ID: 24498323
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
[TBL] [Abstract][Full Text] [Related]
16. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
[TBL] [Abstract][Full Text] [Related]
17. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
[TBL] [Abstract][Full Text] [Related]
19. Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer.
Fang H; Lai NC; Gao MH; Miyanohara A; Roth DM; Tang T; Hammond HK
Hum Gene Ther Methods; 2012 Aug; 23(4):234-41. PubMed ID: 22966786
[TBL] [Abstract][Full Text] [Related]
20. The advent of AAV9 expands applications for brain and spinal cord gene delivery.
Dayton RD; Wang DB; Klein RL
Expert Opin Biol Ther; 2012 Jun; 12(6):757-66. PubMed ID: 22519910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
